Short-chain fatty acids: Butyrate, propionate, and acetate directly stimulate GLP-1 secretion
This established the dual agonist mechanisms utility beyond weight loss and is relevant context for the broader mechanistic comparison in metabolic disease research
Before addressing timelines, it is important to define the medication itself
In Schachts study, semaglutide was effective for reducing drinking at a relatively low dose
The trial followed patients who completed 68 weeks of semaglutide 2.4 mg treatment, then discontinued the medication and were followed for an additional 52 weeks off treatment
GLP-1 Injection Site Reactions: Whats Normal, Whats Not, and What to Do GLP-1 injection site reactions are a common part of treatment and rarely a reason to stop therapy